Health Economics and Outcomes Research (HEOR) and Evidence Generation Consultants

A robust, comprehensive evidence base is crucial in demonstrating the effectiveness and, ultimately, the value of your product to payers and other key stakeholders.

Our in-house team of HEOR consultants, health economists, and evidence-based scientists work together to generate the clinical and economic evidence required for internal and external decision-making.

As a leading HEOR and market access consultancy, we combine rigorous academic protocols with a deep understanding of the commercial requirements and budgetary challenges of global healthcare markets. This enables us to generate an evidence base and present data in a way that resonates with reimbursement agencies and local payers.

We can help you develop a roadmap of activities, both strategic and tactical, that will build an evidence-base to support your product’s value proposition.

Our HEOR Services

  • Health economic strategy and model conceptualisation
  • Early economic modelling
  • Global cost-effectiveness and budget impact modelling
  • HTA modelling
  • Supporting statistical analysis
    • Survival analysis – including non-parametric, semi-parametric and fully parametric modelling
    • Mapping of utility values
    • General IPD analysis (working with raw IPD data in ADaM format)
    • Regression analysis
  • Health economic strategy and model conceptualisation
  • Early economic modelling
  • Global cost-effectiveness and budget impact modelling
  • HTA modelling
  • Supporting statistical analysis
    • Survival analysis – including non-parametric, semi-parametric and fully parametric modelling
    • Mapping of utility values
    • General IPD analysis (working with raw IPD data in ADaM format)
    • Regression analysis
  • Evidence generation strategy
  • Systematic literature review
  • Network meta-analysis
  • Bespoke statistical analyses
  • Evidence generation strategy
  • Systematic literature review
  • Network meta-analysis
  • Bespoke statistical analyses

To discuss your HEOR needs with our experts, get in touch using the form below.

    Keep me up to date with the latest news and events.

    “The support from the Mtech Access team was outstanding. The Mtech Access health economists inputted into the systematic reviews to make sure everything ran smoothly for the models. I have come to realise that there are many benefits that come from having the Systematic Review, Network Meta-Analysis and Health Economics models done by the same agency.”

    Global Health Economics DirectorPharma Company

    “Facing pressing resubmission deadlines, we reached out to Mtech Access to update our Systematic Literature Review and Data Analysis. I was very glad we did. We received the optimal outcome given the timelines – overall a very successful project!”

    Global HEOR DirectorPharma Company

    “We realised how important it was when developing a health economic model to have local affiliates involved and engaged from the start, as they are going to be the end users. Working in this way means that the models are mostly adapted to local market needs already at the beginning, which means affiliates will save time and money in the long run as the model is more fit for purpose.”

    Global Health Economics Director Pharma Company

    “The proposal, cost and timelines were all great and I was pleased with the project management. I previously worked at several agencies, so I always think about how much I would have charged for similar services, and your costs were spot on.”

    Communication SpecialistMedical Device Company

    “The health economic modelling for our HTA submission was difficult and complex, but the Mtech Access Health Economist came up with lots of ideas, working with our team to overcome these challenges; it was just like having another colleague around the table.”

    Head of Market Access, UK & IrelandPharma Company

    “Honestly, the best agency I have ever worked with. It felt like we were working with a partner and not an agency! The Mtech Access Evidence Consultant we worked with was the driving force for this project’s success. She set up the scope and plan, nailed the systematic review protocol and delivered great quality work requiring very few changes. The manuscript is now a central piece of evidence in our work with external stakeholders; it is a high-quality piece of work that is proving vital to our conversations.”

    Global Medical DirectorTop 20 Pharma Company

    HEOR news and insights

    The value of early-stage health economic models - an interview with Elizabeth Thurgar - Director, Health Economics

    The value of early-stage health economic models – an interview with Elizabeth Thurgar

    Elizabeth Thurgar recently joined Mtech Access as a Director in our Health Economics team. In this interview, she tells us about her experiences and activities in her first few weeks…

    Accelerating evidence synthesis in an infodemic

    Accelerating evidence synthesis in an infodemic

    On World Evidence-Based Healthcare Day (20th October 2021), Shona Lang (Senior Consultant -Evidence Synthesis), Stephanie Swift (Consultant – Evidence Synthesis) and Calum Jones (Consultant Health Economist) explore the role of…

    Valuing patient safety data

    To celebrate World Patient Safety Day 2021, Dr Stephanie Swift and Dr Shona Lang, Consultant and Senior Consultant in Systematic Reviews and Evidence Synthesis at Mtech Access, highlight some of…